Health Care & Life Sciences » Biotechnology | Nymox Pharmaceutical Corp.

Nymox Pharmaceutical Corp. | Mutual Funds

Mutual Funds that own Nymox Pharmaceutical Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
iShares Russell 2000 ETF
732,555
1.21%
0
0%
09/06/2018
iShares Russell 2000 Value ETF
225,121
0.37%
0
0.01%
09/06/2018
iShares Russell 2000 Growth ETF
131,716
0.22%
0
0%
09/06/2018
iShares Micro Cap ETF
85,844
0.14%
0
0.02%
09/06/2018
Fidelity Spartan Small Cap Index Fund
63,876
0.11%
941
0%
04/30/2018
CREF Stock Account
58,016
0.1%
0
0%
03/31/2018
Schwab Small Cap Index Fund
50,400
0.08%
0
0%
06/30/2018
AXA 2000 Managed Volatility Portfolio
40,838
0.07%
0
0%
03/31/2018
Vanguard Russell 2000 Index Fund
37,804
0.06%
676
0%
07/31/2018
TIAA-CREF Small Cap Blend Index Fund
33,197
0.06%
0
0%
05/31/2018

About Nymox Pharmaceutical

View Profile
Address
Bay & Deveaux Streets
Nassau NW
Bahamas
Employees -
Website http://www.nymox.com
Updated 07/08/2019
Nymox Pharmaceutical Corp.operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.